Cargando…
Advances in targeted therapies and new promising targets in esophageal cancer
Esophageal cancer, comprising squamous carcinoma and adenocarcinoma, is a leading cause of cancer-related death in the world. Notably, the incidence of esophageal adenocarcinoma has increased at an alarming rate in the Western world. Unfortunately, the standard first-line chemo-radiotherapeutic appr...
Autores principales: | Belkhiri, Abbes, El-Rifai, Wael |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4359299/ https://www.ncbi.nlm.nih.gov/pubmed/25593196 |
Ejemplares similares
-
Aurora kinase A in gastrointestinal cancers: time to target
por: Katsha, Ahmed, et al.
Publicado: (2015) -
DARPP-32: from neurotransmission to cancer
por: Belkhiri, Abbes, et al.
Publicado: (2016) -
Altered expression of AXL receptor tyrosine kinase in gastrointestinal cancers: a promising therapeutic target
por: Pidkovka, Nataliya, et al.
Publicado: (2023) -
The Aurora kinase A Regulates GSK-3β in Gastric Cancer Cells
por: Dar, Altaf A, et al.
Publicado: (2008) -
Deciphering the Unique MicroRNA Signature in Human Esophageal Adenocarcinoma
por: Saad, Rama, et al.
Publicado: (2013)